T. Meyer

QT-screen: high-throughput cardiac safety pharmacology by extracellular electrophysiology on primary cardiac myocytes.

T. Meyer, Christine Leisgen, B. Gonser, 2004, Assay and drug development technologies.

New cell models and assays in cardiac safety profiling.

T. Meyer, Christine Leisgen, P. Sartipy, 2007, Expert opinion on drug metabolism & toxicology.

Cardiac slices as a predictive tool for arrhythmogenic potential of drugs and chemicals

Udo Kraushaar, T. Meyer, U. Kraushaar, 2010, Expert opinion on drug metabolism & toxicology.

New cell models and assays in cardiac safety profiling

T. Meyer, Christine Leisgen, P. Sartipy, 2007 .

Recent withdrawals of prescription drugs from clinical use because of unexpected side effects on the heart have highlighted the need for more reliable cardiac safety pharmacology assays. Block of the human Ether-a-go go Related Gene (hERG) ion

R. Passier, C. Mummery, T. Meyer, 2010 .

Microelectrode Arrays in Cardiac Mapping

T. Meyer, U. Kraushaar, E. Guenther, 2012 .

Cardiac safety pharmacology: from human ether-a-gogo related gene channel block towards induced pluripotent stem cell based disease models

T. Meyer, U. Kraushaar, D. Hess, 2012, Expert opinion on drug safety.